Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

BackgroundEGFR exon 20 insertions (EGFR ex20ins) constitute a heterogeneous subset of EGFR-activating alterations. However, the effectiveness of standard therapy in patients with EGFR ex20ins remains poor.MethodsIn our study, we retrospectively collected next-generation sequencing (NGS) data from 7,...

Full description

Bibliographic Details
Main Authors: Chao Shi, Ruyue Xing, Mengmeng Li, Junnan Feng, Rui Sun, Bing Wei, Yongjun Guo, Jie Ma, Huijuan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
EGFR exon20 insertion
near loop
far loop
clinical treatment outcomes
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.949304/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.949304/full

Similar Items